Table 71-1.
Clinical Findings and Treatment* in Lyme Disease
| Stage (Time from Initial Exposure) | Treatment† |
|---|---|
| Early Localized (7–14 days) | |
| Erythema migrans | Amoxicillin 50 mg/kg/day divided bid or |
| Doxycycline‡ 100 mg bid × 14–21 days | |
| Early Disseminated (days to weeks) | |
| Multiple erythema migrans | Amoxicillin (as above) × 21–28 days |
| Neurologic | |
| Cranial neuropathy (Bell's palsy) | Amoxicillin (as above) × 21–28 days |
| Radiculoneuritis | Amoxicillin (as above) × 21–28 days |
| Aseptic meningitis/encephalitis | Ceftriaxone 75–100 mg/kg/day × |
| 14–28 days or 30–60 days depending on clinical response | |
| Cardiac | |
| Myopericarditis | Ceftriaxone (as above) × 14–21 days |
| Atrioventricular block | Cardiology consult |
| Cardiomegaly | Cardiology consult |
| Musculoskeletal | |
| Arthralgias | Supportive care |
| Myalgias | Supportive care |
| Late Disseminated (weeks to months) | |
| Arthritis | Amoxicillin (as above) × 28 days |
| Chronic polyneuropathy | Supportive care |
| Chronic encephalopathy§ | Supportive care |
Treatment for Lyme disease may have different recommendations from different sources; consultation with an infectious disease expert should be considered.
Cefuroxime axetil or erythromycin can be used for penicillinallergic patients.
Only in children 8 years or older.
Sleep disturbance, fatigue, mood changes, concentration difficulty, and memory loss.